The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction

por Zastrozhin, Mikhail Sergeevich, Grishina, Elena Anatolievna, Ryzhikova, Kristina Anatolievna, Smirnov, Valery Valerievich, Savchenko, Ludmila Mikhailovna, Bryun, Evgeny Alekseevich, Sychev, Dmitry Alekseevich
Publicado 2017

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

por Zastrozhin, Mikhail Sergeevich, Brodyansky, Vadim Markovich, Skryabin, Valentin Yurievich, Grishina, Elena Anatolievna, Ivashchenko, Dmitry Vladimirovich, Ryzhikova, Kristina Anatolievna, Savchenko, Ludmila Mikhaylovna, Kibitov, Alexander Olegovich, Bryun, Evgeny Alekseevich, Sychev, Dmitry Alekseevich
Publicado 2017

Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke

por Kryukov, Alexander Valerevich, Sychev, Dmitry Alekseevich, Andreev, Denis Anatolevich, Ryzhikova, Kristina Anatolievna, Grishina, Elena Anatolievna, Ryabova, Anastasia Vladislavovna, Loskutnikov, Mark Alekseevich, Smirnov, Valeriy Valerevich, Konova, Olga Dmitrievna, Matsneva, Irina Andreevna, Bochkov, Pavel Olegovich
Publicado 2018